Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation Using a Circular Multipolar Ablation Catheter: Safety and Efficacy Using Low-Power Settings

Journal of Cardiovascular Electrophysiology

Volumn 27, Issue 2, 2016, Pages 170-174

  Burri, Haran ^a,b   Park, Chan Il ^a   Poku, Nana ^a   Giraudet, Philippe ^a   Stettler, Carine ^b   Zimmermann, Marc ^a  

^a LA TOUR HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

atrioesophageal injury; efficacy; nMARQ; paroxysmal atrial fibrillation; radiofrequency catheter ablation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION CATHETER; ADULT; ARTICLE; ATRIAL FIBRILLATION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; DEVICE SAFETY; ESOPHAGUS FISTULA; ESOPHAGUS INJURY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAROXYSMAL ATRIAL FIBRILLATION; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIOFREQUENCY; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; ACTION POTENTIAL; ADVERSE EFFECTS; AGED; DEVICES; EQUIPMENT DESIGN; HEART CATHETER; HEART CATHETERIZATION; HEART FUNCTION TEST; HEART RATE; INJURIES; KAPLAN MEIER METHOD; PARALYSIS; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURIES; PHRENIC NERVE; PULMONARY VEIN; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC CATHETERS; CATHETER ABLATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; FEMALE; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PARALYSIS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERIPHERAL NERVE INJURIES; PHRENIC NERVE; PULMONARY VEINS; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84956701898     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12853     Document Type: Article

References (16)

1. Shin DI, Kirmanoglou K, Eickholt C, Schmidt J, Clasen L, Butzbach B, Rassaf T, Merx M, Kelm M, Meyer C,: Initial results of using a novel irrigated multielectrode mapping and ablation catheter for pulmonary vein isolation. Heart Rhythm 2014; 11: 375-383.
2. Deneke T, Schade A, Muller P, Schmitt R, Christopoulos G, Krug J, Szollosi G, Mugge A, Kerber S, Nentwich K,: Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. J Cardiovasc Electrophysiol 2014; 25: 339-345.
3. Mahida S, Hooks DA, Nentwich K, Ng GA, Grimaldi M, Shin DI, Derval N, Sacher F, Berte B, Yamashita S, Denis A, Hocini M, Deneke T, Haissaguerre M, Jais P., nMARQ ablation for atrial fibrillation: Results from a multicentre study. J Cardiovasc Electrophysiol 2015; 26: 724-729.
4. Rillig A, Lin T, Burchard A, Kamioka M, Heeger C, Makimoto H, Metzner A, Wissner E, Wohlmuth P, Ouyang F, Kuck KH, Tilz RR,: Modified energy settings are mandatory to minimize oesophageal injury using the novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. Europace 2015; 17: 396-402.
5. Di Monaco A, Quadrini F, Katsouras G, Caccavo V, Troisi F, Quatraro F, Cecere G, Langialonga T, Grimaldi M,: Ablation of atrial fibrillation and esophageal injury: Role of bipolar and unipolar energy using a novel multipolar irrigated ablation catheter. Heart Rhythm 2015; 12: 1120-1127.
6. Deneke T, Schade A, Diegeler A, Nentwich K,: Esophago-pericardial fistula complicating atrial fibrillation ablation using a novel irrigated radiofrequency multipolar ablation catheter. J Cardiovasc Electrophysiol 2014; 25: 442-443.
7. Yousuf O, Calkins H,: Sounding the warning on the potential for oesophageal injury resulting from use of the nMARQ™ for ablation of atrial fibrillation. Europace 2015; 17: 343-344.
8. Arroja JD, Zimmermann M,: Phrenic nerve lesion: A potential complication of the nMARQ ablation technique. Int J Cardiol 2015; 180: 91-92.
9. Scaglione M, Caponi D, Anselmino M, Di Clemente F, Blandino A, Ferraris F, Di Donna P, Ebrille E, Halimi F, Leclercq JF, Iunco C, Vaudagna C, Cesarani F, Gaita F,: Pulmonary vein isolation with a new multipolar irrigated radiofrequency ablation catheter (nMARQ): Feasibility, acute and short-term efficacy, safety, and impact on postablation silent cerebral ischemia. J Cardiovasc Electrophysiol 2014; 25: 1299-1305.
10. Deneke T, Muller P, Halbfass P, Szollosi A, Roos M, Krug J, Fochler F, Schade A, Schmitt R, Christopoulos G, Mugge A, Nentwich K,: Effect of different ablation settings on acute complications using the novel irrigated multipolar radiofrequency ablation catheter (nMARQ). J Cardiovasc Electrophysiol 2015; 15: 12736.
11. Rosso R, Halkin A, Michowitz Y, Belhassen B, Glick A, Viskin S,: Radiofrequency ablation of paroxysmal atrial fibrillation with the new irrigated multipolar nMARQ ablation catheter: Verification of intracardiac signals with a second circular mapping catheter. Heart Rhythm 2014; 11: 559-565.
12. Pavlovic N, Sticherling C, Knecht S, Reichlin T, Muhl A, Schaer B, Osswald S, Kuhne M,: One-year follow-up after irrigated multi-electrode radiofrequency ablation of persistent atrial fibrillation. Europace 2015 [Epub ahead of print].
13. Mugnai G, de Asmundis C, Ciconte G, Irfan G, Saitoh Y, Velagic V, Stroker E, Wauters K, Hunuk B, Brugada P, Chierchia GB,: Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: A large single-center study of 500 consecutive patients. Heart Rhythm 2015; 12: 1476-1482.
14. Ahsan SY, Flett AS, Lambiase PD, Segal OR,: First report of phrenic nerve injury during pulmonary vein isolation using the Ablation Frontiers pulmonary vein ablation catheter. J Intervcardiac Electrophysiol 2010; 29: 187-190.
15. Muller P, Dietrich JW, Halbfass P, Abouarab A, Fochler F, Szollosi A, Nentwich K, Roos M, Krug J, Schade A, Mugge A, Deneke T,: Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm 2015; 12: 1464-1469.
16. Verma A, Debruyne P, Nardi S, Deneke T, DeGreef Y, Spitzer S, Balzer JO, Boersma L,: Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: Results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol 2013; 6: 835-842.